TSHA SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001231919-26-000928
TSHA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G for Taysha Gene Therapies, indicating a change in passive ownership position. The stock moved -0.7% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Taysha Gene Therapies, indicating a change in passive ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
Key details
How TSHA stock reacted
Close before
$5.99
Aug 13, 2026
First close after
-0.67%
$5.95
5 trading days
+2.00%
$6.11
Since filing
-27.71%
$4.33
✦ Ask GOAX AI about this filing — what it means for TSHA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TSHA?
Click hereFrequently asked questions
What did TSHA file with the SEC on Aug 14, 2026?
TSHA filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Taysha Gene Therapies, indicating a change in passive ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did TSHA stock react to this filing?
TSHA closed at $5.99 before the filing and $5.95 on Aug 14, 2026 (-0.67%). Five trading days later: $6.11 (+2.00%).
Other TSHA SEC filings
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 144 · Insider sale plannedJul 10, 2026
- 424B5 · Secondary offeringJun 25, 2026
- 8-K · Secondary offeringJun 25, 2026
- 424B5 · Secondary offeringJun 24, 2026
- 8-K · Fda approvalJun 22, 2026
- 8-K · SEC filingJun 2, 2026
- 8-K · SEC filingMay 6, 2026
Get alerts when TSHA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days